Cullinan Therapeutics, Inc. (CGEM)
14.74
-0.21
(-1.40%)
USD |
NASDAQ |
Apr 16, 16:00
14.73
-0.01
(-0.07%)
After-Hours: 20:00
Cullinan Therapeutics Market Cap : 892.15M for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 42.46B |
| Regeneron Pharmaceuticals, Inc. | 78.87B |
| MacroGenics, Inc. | 216.73M |
| Xencor, Inc. | 913.07M |
| Nkarta, Inc. | 199.61M |
Market Cap Related Metrics
| PEG Ratio | -0.2111 |
| Price to Book Value | 2.183 |
| Price | 14.74 |
| Earnings Yield | -25.26% |
| PEGY Ratio | -0.2111 |